Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers

Completed · Phase 2 · Has a placebo group

Conditions studied: Obesity

In brief

The purpose of this study is to determine whether CP-866,087 is effective in the weight loss of overweight patients.

Key facts

Study ID

NCT00479492

Run by

Pfizer

People needed

94

Starts

2007-06-01

Expected to finish

2008-01-01

Last updated by the study team

2009-10-01

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Body Mass Index (BMI) 30 to 40 kg/m2 and total body weight of >110 lbs.
• Otherwise healthy

You may not qualify if…

• Women must be of non-childbearing potential.
• Significant current or history of medical illness.

Where it is running

• Pfizer Investigational Site — Orlando, Florida, United States
• Pfizer Investigational Site — Kalamazoo, Michigan, United States
• Pfizer Investigational Site — Portland, Oregon, United States
• Pfizer Investigational Site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.